Palette Life Sciences Announces FDA 510(k) Clearance for Barrigel® Rectal Spacer, Proven Safe and Effective at Minimizing the Harmful Long-Term Side Effects of Prostate Radiation Therapy - Palette Life Sciences

Groundbreaking technology introduces increased control to achieve optimal coverage proven to significantly reduce the risk of toxicity to the rectum SANTA BARBARA, CALIF. / STOCKHOLM, SWEDEN – June 9, 2022— Palette Life Sciences, a fully-integrated global life sciences company dedicated to improving patient outcomes, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of […]

Frontiers Rationale for Utilization of Hydrogel Rectal Spacers

Salvage therapy for prostate cancer after radical prostatectomy

Barrigel prostate spacer

Helena Jansson på LinkedIn: Palette Life Sciences Announces FDA

Barrigel® Rectal Spacing

CAROL THRONDSON on LinkedIn: Barrigel Rectal Spacer Procedure

Barrigel® Rectal Spacing

Cancers, Free Full-Text

Rick Wymer on LinkedIn: Palette Life Sciences Announces FDA 510(k

Barrigel on LinkedIn: Palette Life Sciences Announces FDA 510(k

SpaceOAR - Augmenix, Boston Scientific, and Conflicts of Interest

Palette Life Sciences Announces Publication of Barrigel® Pivotal

Barrigel Spacer Minimize Prostate Radiation Side Effects

Vinny Devany on LinkedIn: Palette Life Sciences Announces FDA 510